Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice

Journal of Immunology

Volumn 182, Issue 6, 2009, Pages 3678-3687

  Conrady, Christopher D ^a   Thapa, Manoj ^a   Wuest, Todd ^a   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN STEM; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; INFECTION; INFECTION SENSITIVITY; LYMPH NODE; MACROPHAGE; MALE; MANDIBLE; MOUSE; NATURAL KILLER T CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRIGEMINUS NEURALGIA; UPREGULATION; VIRUS INFECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; HERPES SIMPLEX; IMMUNOLOGY; INNATE IMMUNITY; MOUSE MUTANT; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIROLOGY; VIRUS REPLICATION;

ANIMALS; BRAIN STEM; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; MANDIBLE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TRIGEMINAL GANGLION; VIRUS REPLICATION;

EID: 65449176429     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803878     Document Type: Article

References (70)

1. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6: 975-990.
2. Sadler, A. J., and B. R. G. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8: 559-568.
3. Uze, G., G. Schreiber, J. Piehler, and S. Pellegrini. 2007. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316: 71-95.
4. Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, et al. 2003. Impaired response to interferon-α/β and lethal viral diseases in human STAT1 deficiency. Nat. Genet. 33: 388-391.
5. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
6. Halford, W. P., C. Weisend, J. Grace, M. Soboleski, D. J. J. Carr, J. W. Balliet, Y. Imai, T. P. Margolis, and B. M. Gebhardt. 2006. ICP0 antagonizes Stat I-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virology J. 3: 44.
7. Yokota, S.-I., N. Yokosawa, T. Kubota, T. Suzutani, I. Yoshida, S. Miura, K. Jimbow, and N. Fujii. 2001. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and Janus kinases during an early infection stage. Virology 286: 119-124.
8. Cassady, K. A., M. Gross, and B. Roizman. 1998. The second-site mutation in herpes simplex virus recombinants lacking the γ134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2α. J. Virol. 72: 7005-7011.
9. + T lymphocytes. Cell 77: 525-535.
10. Fruh, K., K. Ahn, H. Djaballay, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
11. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
12. Neumann, J., A. M. Eis-Hubinger, and N. Koch. 2003. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 171: 3075-3083.
13. Sloan, D. D., J. Y. Han, T. K. Sandifer, M. Stewart, A. J. Hinz, M. Yoon, D. C. Johnson, P. G. Spear, and K. R. Jerome. 2006. Inhibition of TCR signaling by herpes simplex virus. J. Immunol. 176: 1825-1833.
14. Sloan, D. D., G. Zahariadis, C. M. Posavad, N. T. Pate, S. J. Kussick, and K. R. Jerome. 2003. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J. Immunol. 171: 6733-6741.
15. Han, J. Y., D. D. Sloan, M. Aubert, S. A. Miller, C. H. Dang, and K. R. Jerome. 2007. Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus. Virology 359: 253-263.
16. Salio, M., M. Cella, M. Suter, and A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29: 3245-3253.
17. Mikloska, Z., L. Bosnjak, and A. L. Cunningham. 2001. Immature monocytederived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75: 5958-5964.
18. Pollara, G., K. Speidel, L. Samady, M. Rajpopat, Y. McGrath, J. Ledermann, R. S. Coffin, D. R. Katz, and B. Chain. 2003. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187: 165-178.
19. Samady, L., E. Costigliola, L. MacCormac, Y. McGrath, S. Cleverley, C. E. Lilley, J. Smith, D. S. Latchman, B. Chain, and R. S. Coffin. 2003. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs-HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 77: 3768-3776.
20. Muller, D. B., M. J. Raftery, A. Kather, T. Giese, and G. Schonrich. 2004. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur. J. Immunol. 34: 941-951.
21. Bosnjak, L., M. Miranda-Saksena, D. M. Koelle, R. A. Broadle, C. A. Jones, and A. L. Cunningham. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174: 2220-2227.
22. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189: 521-529.
23. +, α/β T-cell receptor-positive T lymphocytes with the capacity to produce γ interferon. J. Virol. 76: 9298-9406.
24. Paquette, R. I., N. C. Hsu, S. M. Kiertscher, A. N. Park, L. Tran, M. D. Roth, and J. A. Glaspy. 1998. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukocyte Biol. 64: 358-367.
25. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
26. Montoya, M., G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99: 3263-3271.
27. Leib, D. A., T. E. Harrison, K. M. Laslo, M. A. Machelek, N. J. Moorman, and H. W. Virgin. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189: 663-672.
28. Luker, G. D., J. L. Prior, J. Song, C. M. Pica, and D. A. Leib. 2003. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 77: 11082-11093.
29. Garvey, T. L., K. D. Dyer, J. A. Ellis, C. A. Bonville, B. Foster, C. Prussin, A. J. Easton, J. B. Domachowske, and H. F. Rosenberg. 2005. Inflammatory responses to pneumovirus infection in IFN-αβ R gene-deleted mice. J. Immunol. 175: 4735-4744.
30. Mueller, S. N., W. R. Heath, J. D. McLain, F. R. Carbone, and C. M. Jones. 2002. Characterization of two TCR TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80: 156-163.
31. Halford, W. P., B. M. Gebhardt, and D. J. J. Carr. 1996. Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70: 5051-5060.
32. + T cells are required for adenovirus vector: IFN-γ inhibition of herpes simplex virus-1 in cornea. J. Immunol. 178: 5166-5172.
33. Wuest, T., and D. J. J. Carr. 2008. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the anti-viral response to HSV-1 Infection. J. Immunol. 181: 7985-7993.
34. Mueller, S. N., W. Heath, J. D. McLain, F. R. Carbone, and C. M. Jones. 2002. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80: 156-163.
35. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101: 1315-1320.
36. Carr, D. J. J., and I. L. Campbell. 2006. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system. Viral Immunol. 19: 741-746.
37. + T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb. Pathog. 27: 387-394.
38. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191: 1459-1466.
39. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172: 392-397.
40. + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
41. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
42. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756.
43. Lee, C.-K., D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165: 3571-3577.
44. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
45. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-α β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
46. H1 priming. Nat. Immunol. 5: 1260-1265.
47. Darnell, J. E. Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
48. + T cells and monocytes. Blood 87: 4731-4736.
49. Moore, K. W., A. O'Garra, R. de Wall Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-190.
50. Salazar-Mather, T. P., C. A. Lewis, and C. A. Biron. 2002. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J. Clin. Invest. 110: 321-330.
51. Wuest, T., B. A. Austin, S. Uematsu, M. Thapa, S. Akira, and D. J. J. Carr. 2006. Intact TLR9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 179: 46-52.
52. Noppert, S. J., K. A. Fitzgerald, and P. J. Hertzog. 2007. The role of type I interferons in TLR responses. Immunol. Cell Biol. 85: 446-457.
53. Lundberg, P., C. Ramakrishna, J. Brown, J. M. Tyszka, M. Hamamura, D. R. Hinton, S. Kovats, O. Nalcioglu, K. Weinberg, H. Openshaw, and E. M. Cantin. 2008. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J. Virol. 82: 7078-7088.
54. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166: 5448-5455.
55. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
56. Prooietti, E., L. Bracci, S. Puzelli, T. Di Pucchio, P. Sestili, E. De Vincenzi, M. Venditti, I. Capone, I. Seif, E. De Maeyer, et al. 2002. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J. Immunol. 169: 375-383.
57. McRae, B. L., R. T. Semnani, M. P. Hayes, and G. A. van Seventer. 1998. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160: 4298-4304.
58. Kruse, M., O. Rosorius, F. Kratzer, G. Stelz, C. Kuhnt, G. Schuler, J. Hauber, and A. Steinkasserer. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Immunol. 74: 7127-7136.
59. Matheu, V., A. Treschow, V. Navikas, and S. Issazadeh-Navikas. 2003. Upregulation of B7 molecules (CD80 and CD86) and exacerbated eosinophilic pulmonary inflammatory response in mice lacking the IFN-β gene. J. Allergy Clin. Immunol. 111: 550-557.
60. Freedman, A. S., G. J. Freedman, K. Rhynhart, and L. M. Nadler. 1991. Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 137: 429-437.
61. Ren, G., J. Su, X. Zhao, L. Zhang, J. Zhang, A. I. Roberts, H. Zhang, G. Das, and Y. Shi. 2008. Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-γ and nitric oxide. J. Immunol. 181: 3277-3284.
62. + T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168: 4907-4913.
63. + T cells stimulated by virusinduced type I interferon. Nat. Immunol. 4: 1009-1015.
64. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. M. Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637- 650.
65. Thompson, L. J., G. A. Kolumam, S. Thomas, and K. Murali-Krishna. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177: 1746-1754.
66. Nahmias, A. J., and B. Roizman. 1973. Infection with herpes simplex viruses 1 and 2. New Engl. J. Med. 289: 781-789.
67. Halperin, S. A., Z. Shehab, D. Thacker, and J. O. Hendley. 1983. Absence of viremia in primary herpetic gingivostomatitis. Pediatr. Infect. Dis. 2: 452-453.
68. Harel, L., Z. Smetana, D. Prais, M. Book, M. Alkin, E. Supaev, E. Mendelson, and J. Amir. 2004. Presence of viremia in patients with primary herpetic gingivostomatitis. Clin. Infect. Dis. 39: 636-640.
69. Carr, D. J. J., J. Chodosh, J. Ash, and T. E. Lane. 2003. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77: 10037-10046.
70. Gilden, D. H., R. Mahalingam, R. J. Cohrs, and K. L. Tyler. 2006. Herpesvirus infectious of the nervous system. Nat. Clin. Pract. Neurol. 3: 82-94.